|
|
| Year:
2026 |
Month:
October
|
Volume:
15 |
Issue:
4 |
Page:
PO29 - PO32 |
Coagulation Abnormalities in Patients with Multiple Myeloma: A Cross-sectional Study from a Tertiary Care Centre in Southern India
|
| |
Correspondence
Leann Elizabeth Lenoy, G Jayapriya, PV Priya, V Letha, Dr. G Jayapriya,
Department of Pathology, Government Medical College, Ernakulam, Kerala, India.
E-mail: ampriya1983@gmail.com :
|
 |
Introduction: Multiple Myeloma (MM) is a haematologic malignancy characterised by clonal plasma cell proliferation in the bone marrow. Coagulation abnormalities are common in MM patients and can result from thrombocytopenia due to disease load, acquired platelet dysfunction, anticoagulant activity of paraproteins, acquired coagulation factor deficiency, enhanced clearance of coagulation factors by reticuloendothelial system, hyperviscocity. These result in haemorrhagic and thrombotic episodes which are associated with poor prognosis and also impact treatment decisions. Early identification of coagulation abnormalities can help in anticipating complications, guiding supportive management, and improving patient outcomes. Hence, evaluating the coagulation profile in patients with MM is important and will provide valuable insights into the association between plasma cell dyscrasia and haemostatic derangements.
Aim: To describe the coagulation profile in patients with MM diagnosed on bone marrow examination and to assess the relationship between coagulation abnormalities, bleeding manifestations, aggressive cellular morphology and disease stage.
Materials and Methods: This cross-sectional study examined 67 newly diagnosed MM patients diagnosed in Government Medical College, Kottayam, Kerala, India between July 2023 to December 2024. Clinical, radiological, and laboratory parameters were assessed, which included total blood count, Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Thrombin Time (TT), and fibrinogen levels. Prolonged PT, APTT, TT and a low or elevated fibrinogen levels were considered as presence of coagulation abnormalities. The association between coagulation abnormalities and bleeding manifestations and plasmablastic morphology were evaluated using Chi-square test. The association between coagulation abnormalities and International Staging System (ISS) stage was evaluated using Fisher-Freeman-Halton exact test. A p-value <0.05 was considered statistically significant.
Results: The study population included 35 (52.2%) males, with mean age of 67 years. Bleeding manifestations were seen in 16 (23.9%) cases. Coagulation abnormalities were found in 19 (28.4%) of patients, with prolonged PT in 8 (11.9%), prolonged APTT in 10 (14.9%), and prolonged TT in 3 (4.5%). Abnormal coagulation was associated with bleeding manifestations (Chi-square test, p-value- 0.001), advanced ISS stage (Fisher-Freeman-Halton exact test, p-value<0.001), and plasmablastic morphology in bone marrow (Chi-square test, p-value=0.011).
Conclusion: Acquired coagulation abnormalities can occur in a significant proportion of newly diagnosed MM patients and can be associated with advanced ISS stage (coagulation abnormalities were most common in stage 3 patients) and plasmablastic morphology, which represents a more aggressive disease variant. Routine coagulation screening should be incorporated into the management of MM patients, especially those in advanced ISS stages or with plasmablastic morphology.
|
| |
[ FULL
TEXT ] | [ ]
|
| |
Print
|
|